Clinical Trials Directory

Trials / Completed

CompletedNCT01053741

Effect of Seminal Fluid on the Colon Wall; Implications for HIV Transmission

The Effect of Seminal Fluid on Distal Colon Mucosal Permeability and Susceptibility to HIV Infection

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
11 (actual)
Sponsor
Johns Hopkins University · Academic / Other
Sex
Male
Age
21 Years
Healthy volunteers
Accepted

Summary

This research is being done to learn how seminal fluid affects the lining of the colon, and whether this might make it easier for HIV to get into the body and cause infection.

Detailed description

Design of effective rectal microbicides to prevent HIV infection requires an understanding of rectal HIV transmission and the location within the lower gastrointestinal (GI) tract (luminal and mucosal) of HIV (cell-free and cell-associated) following exposure to infected seminal fluid. These basic details of HIV transmission have yet to be determined in human subjects, yet they are essential to select microbicide candidates if they are to be rationally designed to achieve effective concentrations at sites of HIV transmission. Rational development of a rectal microbicide also requires an understanding of those factors that may contribute to colonic mucosal injury - potential confounders of microbicidal effect. Such factors include exposure to seminal fluid which has been shown in animal and in vitro studies to cause histologic and permeability changes that might facilitate HIV transmission.

Conditions

Interventions

TypeNameDescription
BIOLOGICALRadiolabeled autologous seminal fluidAutologous lymphocytes labeled with 250 microcuries In-111 and 500 microcuries Tc-99m in seminal fluid vehicle.
BIOLOGICALRadiolabeled Normosol-RAutologous lymphocytes labeled with 250 microcuries In-111 and 500 microcuries Tc-99m in Normosol-R fluid vehicle.

Timeline

Start date
2008-03-01
Primary completion
2009-12-01
Completion
2009-12-01
First posted
2010-01-21
Last updated
2017-05-25
Results posted
2017-05-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01053741. Inclusion in this directory is not an endorsement.